Security Snapshot

NeuroPace Inc - Common Stock, $0.01 par value (NPCE) Institutional Ownership

CUSIP: 641288105

13F Institutional Holders and Ownership History from Q2 2021 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

112

Shares (Excl. Options)

26.58MFull value: 26,576,571 · shares · 30 Jun 2026

Price

$15.89

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, $0.01 par value
Symbol
NPCE on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
26,576,571
Latest holder snapshot 5 signals
Total 13F value
$422,384,052
Portfolio coverage rank
0%
Share change
+109,002
Value change
+$2,979,054
Number of holders
112
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
34,317,804
SEC-reported price per share
$13.76
Insider filing price
$13.76
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NPCE - NeuroPace Inc - Common Stock, $0.01 par value is tracked under CUSIP 641288105.
  • 112 institutions reported positions in Q2 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 113 to 112 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $347.86MFull value: $347,860,387 · USD · 31 Mar 2026
    to
    $422.38MFull value: $422,384,052 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 112 institutions filings for Q2 2026.

Open SEC evidence

Security key

641288105

13F reference period

Q2 2026

13F holders

112

13D/G owners

7

CIK / CUSIP context first

Open Q2 2026 holders NPCE full holder history NeuroPace Inc SEC filings NeuroPace Inc company facts NeuroPace Inc insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
NPCE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Light Asset Management, LLC 12% +40% $62,554,493 +$18,577,799 4,203,931 +42% Mathew P. Arens 31 Aug 2026
Polar Capital Holdings Plc 9.1% $34,534,675 2,972,003 Polar Capital Holdings Plc 31 Mar 2025
Soleus Private Equity Fund I, L.P. 8.9% $30,496,537 2,957,957 Guy Levy 30 Sep 2025
MORGAN STANLEY 8.3% $28,926,723 2,489,391 Morgan Stanley 31 Dec 2024
Soleus Capital Master Fund, L.P. 7% $23,545,122 2,303,828 Soleus Capital Management, L.P. 30 Jun 2025
ORBIMED ADVISORS LLC 4.4% -30% $25,752,689 -$10,118,888 1,505,125 -28% OrbiMed Advisors LLC 30 Jun 2026
Kent Lake PR LLC 4.9% -2% $17,227,289 +$116,944 1,482,555 +0.68% Kent Lake PR LLC 31 Dec 2024
As of 30 Jun 2026, 112 institutional investors reported holding
26.58MFull value: 26,576,571 · shares · 30 Jun 2026
shares of NeuroPace Inc - Common Stock, $0.01 par value (NPCE). This represents 77% of the company’s total
34.32MFull value: 34,317,804 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
71%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Polar Capital Holdings Plc 9.6% 3,298,104 0% 0.15% $52,406,873
Soleus Capital Management, L.P. 8.5% 2,911,122 -0.72% 1.6% $46,257,729
First Light Asset Management, LLC 8.3% 2,861,167 +16% 2.8% $45,463,944
MORGAN STANLEY 7.7% 2,654,391 +3.4% 0% $42,178,273
BlackRock, Inc. 7.2% 2,477,603 +5.6% 0% $39,369,112
ORBIMED ADVISORS LLC 4.4% 1,505,125 -28% 0.45% $23,916,436
Driehaus Capital Management LLC 4.2% 1,447,391 -0.29% 0.13% $22,999,043
VANGUARD CAPITAL MANAGEMENT LLC 3.6% 1,227,072 +9.2% 0% $19,498,174
DEUTSCHE BANK AG\ 2.7% 938,919 +0.73% 0% $14,919,423
ARMISTICE CAPITAL, LLC 2% 692,000 0% 0.3% $10,995,880
GEODE CAPITAL MANAGEMENT, LLC 1.9% 666,300 +7.8% 0% $10,589,998
FMR LLC 1.6% 554,771 +0.22% 0% $8,815,311
STATE STREET CORP 1.6% 550,132 +11% 0% $8,741,597
SILVERCREST ASSET MANAGEMENT GROUP LLC 1% 344,124 -4.4% 0.04% $5,468,130
NORTHERN TRUST CORP 0.76% 260,025 +8.4% 0% $4,131,798
Qube Research & Technologies Ltd 0.64% 221,237 +19% 0% $3,515,456
VANGUARD PORTFOLIO MANAGEMENT LLC 0.64% 220,371 +18% 0% $3,501,695
Palumbo Wealth Management LLC 0.61% 209,199 -0.6% 0.7% $3,324,173
ESSEX INVESTMENT MANAGEMENT CO LLC 0.61% 208,703 -4.1% 0.43% $3,316,291
ALGERT GLOBAL LLC 0.54% 184,774 +2.9% 0.03% $2,936,059
VANGUARD FIDUCIARY TRUST CO 0.53% 182,534 +2.2% 0% $2,900,465
JPMORGAN CHASE & CO 0.51% 173,311 +23% 0% $2,864,831
HighMark Wealth Management LLC 0.47% 163,000 +159% 0.87% $2,590,070
Russell Investments Group, Ltd. 0.47% 162,164 -9.4% 0% $2,576,783
D. E. Shaw & Co., Inc. 0.47% 161,081 +269% 0% $2,559,577

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
22
Headline period
Q2 2026
Rows shown
1-22 of 22
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 206,033 $2,835,013 -$80,860 $13.76 9
2026 Q2 26,576,571 $422,384,052 +$2,979,054 $15.89 112
2026 Q1 26,457,206 $347,860,387 +$8,130,556 $13.15 113
2025 Q4 26,299,826 $405,917,159 +$12,534,292 $15.44 100
2025 Q3 25,945,404 $267,500,978 +$34,175,646 $10.31 80
2025 Q2 22,505,448 $250,711,399 -$19,749,912 $11.14 98
2025 Q1 23,932,784 $294,127,661 +$42,108,506 $12.29 89
2024 Q4 20,868,828 $233,522,000 +$8,990,314 $11.19 61
2024 Q3 14,795,861 $103,125,040 +$1,471,249 $6.97 48
2024 Q2 14,430,601 $109,095,635 +$4,457,712 $7.56 51
2024 Q1 13,364,973 $176,414,273 +$9,053,052 $13.20 53
2023 Q4 12,690,314 $130,836,764 +$2,444,618 $10.31 41
2023 Q3 18,073,997 $175,859,892 +$5,454,271 $9.73 24
2023 Q2 17,503,080 $78,589,150 -$756,243 $4.49 20
2023 Q1 17,670,188 $81,990,736 +$1,754,483 $4.64 24
2022 Q4 17,357,024 $25,862,002 -$2,680,436 $1.49 22
2022 Q3 18,161,017 $68,102,000 -$1,024,177 $3.75 27
2022 Q2 18,426,044 $91,207,000 -$26,340 $4.95 26
2022 Q1 18,210,639 $149,512,180 -$117,404 $8.21 37
2021 Q4 18,012,051 $181,543,000 +$1,949,052 $10.08 41
2021 Q3 11,190,051 $177,393,000 +$509,015 $15.85 39
2021 Q2 10,905,701 $259,451,000 +$259,451,000 $23.79 44
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .